Literature DB >> 12595541

Evidence for the differential effects of nucleocapsid protein on strand transfer in various regions of the HIV genome.

Suchitra S Derebail1, Megan J Heath, Jeffrey J DeStefano.   

Abstract

An in vitro strand transfer assay that mimicked recombinational events occurring during reverse transcription in HIV-1 was used to assess the role of nucleocapsid protein (NC) in strand transfer. Strand transfer in highly structured nucleic acid species from the U3 3' long terminal repeats, gag-pol frameshift region, and Rev response element were strongly enhanced by NC. In contrast, weakly structured templates from the env and pol-vif regions transferred well without NC and showed lower enhancement. The lack of strong polymerase pause sites in the latter regions demonstrated that non-pause driven mechanisms could also promote transfer. Assays conducted using NC zinc finger mutants supported a differential role for the two fingers in strand transfer with finger 1 (N-terminal) being more important on highly structured RNAs. Overall this report suggests a role for structural intricacies of RNA templates in determining the extent of influence of NC on recombination and illustrates that strand transfer may occur by several different mechanisms depending on the structural nature of the RNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595541     DOI: 10.1074/jbc.M211701200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Zinc finger-dependent HIV-1 nucleocapsid protein-TAR RNA interactions.

Authors:  Nick Lee; Robert J Gorelick; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

Review 2.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

3.  In vitro synthesis of long DNA products in reactions with HIV-RT and nucleocapsid protein.

Authors:  Reshma M Anthony; Jeffrey J Destefano
Journal:  J Mol Biol       Date:  2006-10-06       Impact factor: 5.469

4.  Pausing during reverse transcription increases the rate of retroviral recombination.

Authors:  Christian Lanciault; James J Champoux
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 5.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

Review 6.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

7.  Genetic recombination of human immunodeficiency virus type 1 in one round of viral replication: effects of genetic distance, target cells, accessory genes, and lack of high negative interference in crossover events.

Authors:  Terence D Rhodes; Olga Nikolaitchik; Jianbo Chen; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  Structure/function mapping of amino acids in the N-terminal zinc finger of the human immunodeficiency virus type 1 nucleocapsid protein: residues responsible for nucleic acid helix destabilizing activity.

Authors:  Nirupama Narayanan; Robert J Gorelick; Jeffrey J DeStefano
Journal:  Biochemistry       Date:  2006-10-17       Impact factor: 3.162

9.  Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency.

Authors:  Galina N Nikolenko; Evguenia S Svarovskaia; Krista A Delviks; Vinay K Pathak
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Fidelity of plus-strand priming requires the nucleic acid chaperone activity of HIV-1 nucleocapsid protein.

Authors:  Klara Post; Besik Kankia; Swathi Gopalakrishnan; Victoria Yang; Elizabeth Cramer; Pilar Saladores; Robert J Gorelick; Jianhui Guo; Karin Musier-Forsyth; Judith G Levin
Journal:  Nucleic Acids Res       Date:  2009-01-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.